Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORDIC MEDICARE A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.1% 3.5% 14.3% 14.3% 1.3% 1.2% 4.6% 4.6%   Credit score (0-100)   85 53 14 14 79 81 46 46   Credit rating   A BBB BB BB A A BBB BBB   Credit limit (kDKK)   1,651.2 0.0 0.0 0.0 1,182.0 1,543.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   118,733 0 0 0 0 0 0 0   Gross profit   79,660 84,073 0.0 0.0 117,405 133,036 0.0 0.0   EBITDA   12,720 13,396 0.0 0.0 13,650 10,423 0.0 0.0   EBIT   11,136 13,396 0.0 0.0 9,922 8,069 0.0 0.0   Pre-tax profit (PTP)   11,055.5 10,316.0 0.0 0.0 9,809.9 7,894.3 0.0 0.0   Net earnings   8,613.3 10,316.0 0.0 0.0 7,634.3 5,960.7 0.0 0.0   Pre-tax profit without non-rec. items   11,056 13,396 0.0 0.0 9,810 7,894 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   7,810 0.0 0.0 0.0 15,460 33,975 0.0 0.0   Shareholders equity total   18,252 28,567 0.0 0.0 34,452 40,413 33,952 33,952   Interest-bearing liabilities   1,403 0.0 0.0 0.0 85.8 6,939 0.0 0.0   Balance sheet total (assets)   29,921 50,880 0.0 0.0 49,808 60,628 33,952 33,952   Net Debt   -7,190 0.0 0.0 0.0 -10,455 321 -30,921 -30,921     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   118,733 0 0 0 0 0 0 0   Net sales growth   26.6% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   79,660 84,073 0.0 0.0 117,405 133,036 0.0 0.0   Gross profit growth   39.9% 5.5% -100.0% 0.0% 0.0% 13.3% -100.0% 0.0%   Employees   94 102 0 0 128 158 0 0   Employee growth %   20.5% 8.5% -100.0% 0.0% 0.0% 23.4% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   29,921 50,880 0 0 49,808 60,628 33,952 33,952   Balance sheet change%   65.0% 70.0% -100.0% 0.0% 0.0% 21.7% -44.0% 0.0%   Added value   12,720.2 13,396.0 0.0 0.0 9,921.8 10,423.0 0.0 0.0   Added value %   10.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -3,036 -7,810 0 0 15,802 15,122 -33,975 0   Net sales trend   1.0 -1.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 0.0 0.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   10.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   9.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.0% 15.9% 0.0% 0.0% 8.5% 6.1% 0.0% 0.0%   Net Earnings %   7.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   8.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   9.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   46.3% 33.2% 0.0% 0.0% 19.9% 15.0% 0.0% 0.0%   ROI %   69.6% 38.0% 0.0% 0.0% 27.7% 19.4% 0.0% 0.0%   ROE %   61.8% 44.1% 0.0% 0.0% 22.2% 15.9% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   61.0% 100.0% 0.0% 0.0% 69.2% 66.7% 100.0% 100.0%   Relative indebtedness %   9.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   2.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -56.5% 0.0% 0.0% 0.0% -76.6% 3.1% 0.0% 0.0%   Gearing %   7.7% 0.0% 0.0% 0.0% 0.2% 17.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.9% 0.0% 0.0% 0.0% 285.7% 10.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.9 0.0 0.0 0.0 2.0 1.2 0.0 0.0   Current Ratio   1.9 0.0 0.0 0.0 2.0 1.2 0.0 0.0   Cash and cash equivalent   8,593.0 0.0 0.0 0.0 10,540.8 6,617.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   17.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   9,957.3 0.0 0.0 0.0 13,943.1 2,741.4 0.0 0.0   Net working capital %   8.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   1,263 0 0 0 0 0 0 0   Added value / employee   135 131 0 0 78 66 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   135 131 0 0 107 66 0 0   EBIT / employee   118 131 0 0 78 51 0 0   Net earnings / employee   92 101 0 0 60 38 0 0